The U.S. DEA and HHS have extended telemedicine flexibilities for controlled medication prescriptions, initially granted during the COVID-19 pandemic. The extension, lasting six months until November 2023, allows virtual prescribing and promises a grace…
Continue Reading
This past week, the U.S. Drug Enforcement Agency and the U.S. Department of Health and Human Services said it would temporarily extend telemedicine flexibilities for the prescription of certain controlled medications granted under the COVID-19 Public…
Continue Reading
The DEA and SAMHSA have extended telehealth prescribing flexibilities for controlled substances through November 11, 2024, following a temporary rule. The move comes after several healthcare organizations, including the AHA, requested continued telehealth prescribing…
Continue Reading
Pharmacy IT solutions provider Fred IT has won the contract to deliver Australia’s national electronic prescribing delivery service.It will be delivering the service through eRx Script Exchange which shall ensure continuous access to a…
Continue Reading
The Australian government is giving a huge boost to digital health with new funding of A$951.2 million ($643 million) over four years.The 2023-2024 budget for digital health includes:
A$325.7 million ($220 million) to make the…
Continue Reading
What You Should Know:Today, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a…
Continue Reading
By Mark Melchionna
May 08, 2023 – Led by Sen. Edward J. Markey (D-Mass.), a group of US senators have urged the Drug Enforcement Agency (DEA) to permanently establish telehealth flexibilities in prescribing buprenorphine for opioid…
Continue Reading
The U.S. Drug Enforcement Agency (DEA) will extend telemedicine flexibilities around the prescription of certain controlled medications as it considers stakeholder feedback on proposed rules for post-COVID remote prescribing guardrails. The DEA received over…
Continue Reading
Top News
The Drug Enforcement Administration, reacting to the record 38,000 comments it received about its intention to reinstate pre-COVID telehealth prescribing limitations for controlled drugs with the end of the public health emergency, will…
Continue Reading
With the COVID-19 Public Health Emergency set to expire on May 11, the U.S. Drug Enforcement Agency says it will temporarily extend telemedicine flexibilities around prescription of certain controlled medications as it sifts through…
Continue Reading
